Early versus late awake prone positioning in non-intubated patients with COVID-19.
Ramandeep KaurDavid L VinesSara MirzaAhmad ElshafeiJulie A JacksonLauren J HarnoisTyler WeissJ Brady ScottMatthew W TrumpIdrees MogriFlor CerdaAmnah A AlolaiwatAmanda R MillerAndrew M KleinTrevor W OettingLindsey MorrisScott HeckartLindsay CapouchHangyong HeJie LiPublished in: Critical care (London, England) (2021)
Early initiation (< 24 h of HFNC use) of APP in acute hypoxemic respiratory failure secondary to COVID-19 improves 28-day survival. Trial registration ClinicalTrials.gov NCT04325906.